1 / 3

Metabotropic Glutamate Receptor 4 Market Size, Share, Drivers & Trends Analysis to 2017

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Metabotropic glutamate receptor 4 is a protein encoded by the GRM4 gene. It is a G-protein coupled receptor for glutamate.

priyanks0607
Download Presentation

Metabotropic Glutamate Receptor 4 Market Size, Share, Drivers & Trends Analysis to 2017

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Metabotropic Glutamate Receptor 4 Market Size, Share, Drivers & Trends Analysis to 2017 “Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Metabotropic glutamate receptor 4 is a protein encoded by the GRM4 gene. It is a G-protein coupled receptor for glutamate.” Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) pipeline Target constitutes close to 6 molecules. Out of which approximately 5 molecules are developed by companies and remaining by the universities/institutes. The latest report Metabotropic Glutamate Receptor 4 Pipeline Review, H2 2017, outlays comprehensive information on the Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) Metabotropic glutamate receptor 4 is a protein encoded by the GRM4 gene. It is a G-protein coupled receptor for glutamate. Glutamate binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling inhibits adenylate cyclase activity. The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 1 and 2 respectively. Similarly, the universities portfolio in Preclinical stages comprises 1 molecules, respectively. Report covers products from therapy areas Central Nervous System which include indications Parkinson's Disease. Browse Detail Report With TOC @ http://www.hexareports.com/report/metabotropic-glutamate- receptor-4-gprc1d-or-mglur4-or-grm4-pipeline-review-h2-2017 Follow Us:

  2. Furthermore, this report also reviews key players involved in Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope The report provides a snapshot of the global therapeutic landscape for Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) The report reviews Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources Request A Sample copy of This Report @ http://www.hexareports.com/report/metabotropic- glutamate-receptor-4-gprc1d-or-mglur4-or-grm4-pipeline-review-h2-2017/request-sample The report covers pipeline products based on various stages of development ranging from pre- registration till discovery and undisclosed stages The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics and enlists all their major and minor projects The report assesses Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type The report summarizes all the dormant and discontinued pipeline projects The report reviews latest news and deals related to Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics Reasons To Buy 1.Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 2.Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage Follow Us:

  3. 3.Identify and understand the targeted therapy areas and indications for Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) 4.Identify the use of drugs for target identification and drug repurposing 5.Identify potential new clients or partners in the target demographic 6.Develop strategic initiatives by understanding the focus areas of leading companies 7.Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics Browse More Pharmaceuticals & Healthcare Related Market Research Reports: • Complex Regional Pain Syndrome - Pipeline Review, H2 2017 - http://www.hexareports.com/report/complex-regional-pain-syndrome-pipeline-review-h2-2017 • Drug Addiction - Pipeline Review, H2 2017 - http://www.hexareports.com/report/drug-addiction-pipeline-review-h2-2017 • Skin And Soft Tissue Infections - Pipeline Review, H2 2017 - http://www.hexareports.com/report/skin-and-soft-tissue-infections-pipeline-review-h2-2017 About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Follow Us:

More Related